TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News
Investing
Why Tomorrow Is a Big Day for Cannabis Investors
Investing
If You’re Going to Buy a Marijuana Stock, This Is the Only 1 You Should Buy
Investing
This Pot Stock Has More Than Doubled in the Past Month: Is a Buyout on the Horizon?
Energy Stocks
A Fool’s Guide to the Ontario Election
Investing
Pot Stocks Are Starting to Take off Again!
Investing
The Non-TSX Cannabis Play to Make
Investing
How High Can Canopy Growth Stock Go?
Investing
Is Aurora Cannabis Inc.’s (TSX:ACB) Latest Spending Spree Going to Pay Off for its Shareholders?
Investing
This New Pot Stock Could Shake Up the Industry
Dividend Stocks
5 Stocks That Outperformed the TSX This Month
Investing
Will Canopy Growth Corp. (TSX:WEED) Outperform its Peers in 2018 After a U.S. Listing?